ALLMedicine™ Cardiovascular Risk Reduction Center
Research & Reviews 465 results
https://doi.org/10.1016/j.numecd.2022.05.018
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Hashemi A, Vasquez K et. al.
Jun 26th, 2022 - Cardiovascular Disease (CVD) poses significant health risks for seniors, especially among low-income and minority communities. Senior centers offer multiple services. We tested whether implementing two evidence-based interventions- DASH-aligned me...
https://doi.org/10.1186/s13075-022-02836-4 10.1056/NEJMra1406182 10.4078/jrd.2021.28.2.55 10.1056/NEJM199906173402418 10.1056/NEJMra043430 10.1038/nrrheum.2015.112 10.1016/j.semarthrit.2014.10.007 10.7326/M14-2470 10.1093/rheumatology/keaa246 10.1016/S0140-6736(16)31591-4 10.1038/nature01323 10.3132/dvdr.2005.018 10.1002/art.20852 10.1002/art.11325 10.1002/art.21913 10.1002/art.23969 10.1002/art.38721 10.1016/S0140-6736(18)31362-X 10.1093/rheumatology/ket469 10.1136/annrheumdis-2013-203934 10.1136/ard.2009.108233 10.1002/art.1780270401 10.1002/acr.20371 10.1136/annrheumdis-2014-206624 10.1136/ard.2007.086157 10.1161/CIRCULATIONAHA.112.120410 10.1093/rheumatology/ker434 10.1093/rheumatology/kes272 10.1177/1759720X211032444 10.1136/annrheumdis-2016-210770 10.1002/art.41042 10.1136/ard.2006.069211
Arthritis Research & Therapy; Kwon OC, Park MC
Jun 14th, 2022 - Axial spondyloarthritis (axSpA) is associated with an increased risk of cardiovascular disease. We aimed to evaluate the effect of tumor necrosis factor inhibitors (TNFis) on the risk of cardiovascular disease in patients with axSpA. This retrospe...
https://doi.org/10.1164/rccm.202206-1050ED
American Journal of Respiratory and Critical Care Medicine; Pamidi S, Shah N
Jun 9th, 2022 - CPAP and Cardiovascular Risk Reduction in Patients Without Excessive Sleepiness: Importance of the Pulse Rate Response.|2022|Pamidi S,Shah N,|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972581
Journal of the American College of Cardiology; Kelsey MD, Nelson AJ et. al.
May 6th, 2022 - Cardiovascular disease is a leading cause of morbidity and mortality in individuals with type 2 diabetes mellitus. These high-risk patients benefit from aggressive risk factor management, with blood pressure and low-density lipoprotein-cholesterol...
https://doi.org/10.1136/bmj-2021-069116
BMJ (Clinical Research Ed.); Khan SU, Yedlapati SH et. al.
May 5th, 2022 - To compare the impact of ezetimibe and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors on cardiovascular outcomes in adults taking maximally tolerated statin therapy or who are statin intolerant. Network meta-analysis. Medline, EM...
Guidelines 6 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545583
Journal of the American College of Cardiology; Das SR, Everett BM et. al.
Aug 11th, 2020 - 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee.|2020|Das SR,Everett BM,Birtcher KK,Brown...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560953
Journal of the American College of Cardiology; Das SR, Everett BM et. al.
Dec 1st, 2018 - 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Task Force on Expert Consen...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721815
Journal of the American Heart Association; Levine GN, Lange RA et. al.
Oct 1st, 2017 - Despite numerous advances in the prevention and treatment of atherosclerosis, cardiovascular disease remains a leading cause of morbidity and mortality. Novel and inexpensive interventions that can contribute to the primary and secondary preventio...
https://doi.org/10.1016/j.numecd.2016.11.122
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD; Pirro M, Vetrani C et. al.
Dec 14th, 2016 - Evidence showed that LDL-cholesterol lowering is associated with a significant cardiovascular risk reduction. The initial therapeutic approach to hypercholesterolemia includes dietary modifications but the compliance to recommendations is often in...
https://doi.org/10.3928/00904481-20130823-10
Pediatric Annals; Jackson LW
Sep 3rd, 2013 - We all experience that morning rush to get somewhere - to work, to school, or to complete a number of important errands before we reach those final destinations. Many adults skip meals for a variety of reasons. Children and teenagers are no differ...
Drugs 3 results see all →
Clinicaltrials.gov 61 results
https://clinicaltrials.gov/ct2/show/NCT04841902
Apr 19th, 2022 - Adoption of healthy lifestyles by all persons is critical for the prevention of high BP and is an indispensable part of the management of those with hypertension. Weight loss of as little as 10 lbs (4.5 kg) reduces BP and/or prevents hypertension ...
https://clinicaltrials.gov/ct2/show/NCT03167489
Apr 18th, 2022 - Group lifestyle interventions (LI) have documented efficacy in improving cardiovascular disease (CVD) risk factors, however, many fail to demonstrate outcome maintenance. Existing LIs primarily focus on behavioral regulation, neglecting to address...
https://clinicaltrials.gov/ct2/show/NCT03190382
Apr 8th, 2022 - Peripheral arterial disease (PAD) is a burdensome condition that affects 10% of the population and increases to 15-20% among those ≥70 years. In PAD, the underlying pathophysiologic process, atherosclerosis, presents itself as blockages in patient...
https://clinicaltrials.gov/ct2/show/NCT03649204
Mar 14th, 2022 - Peripheral arterial disease (PAD), a disabling condition, affects 800,000 Canadians. People with PAD suffer from poor quality of life due to leg pain, which makes walking difficult. They also have a high risk of heart disease. In November of 2017,...
https://clinicaltrials.gov/ct2/show/NCT05030922
Mar 8th, 2022 - The "Cardiovascular Risk Reduction-Diet in Pregnancy" (CARRDIP) - is a randomised controlled trial with dietary intervention during pregnancy. The participants were enrolled in Norway 20 years ago and consisted of 269 pregnant, healthy mothers. Th...
News 122 results
https://www.medscape.com/viewarticle/975212
Jun 23rd, 2022 - This transcript has been edited for clarity. In the 2022 Management of Hyperglycemia consensus statement from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), the focus has shifted. Regarding t...
https://www.medscape.com/viewarticle/963270
Mar 22nd, 2022 - This transcript has been edited for clarity. Silvio Inzucchi, MD: Welcome to Medscape InDiscussion. I'm your host, Dr Silvio Inzucchi from Yale School of Medicine. Today we're talking about cardiovascular effects of type 2 diabetes medications and...
https://www.medscape.com/viewarticle/968881
Feb 19th, 2022 - A high percentage of people with type 2 diabetes also have atherosclerotic cardiovascular disease (ASCVD), but fewer than 1 in 20 get the triumvirate of evidence-based medications – drugs to lower cholesterol, blood pressure, and glucose levels – ...
https://www.mdedge.com/cardiology/article/251951/diabetes/full-press-therapy-rare-diabetes-ascvd
Richard Mark Kirkner
Feb 18th, 2022 - A high percentage of people with type 2 diabetes also have atherosclerotic cardiovascular disease (ASCVD), but fewer than 1 in 20 get the triumvirate of evidence-based medications – drugs to lower cholesterol, blood pressure, and glucose levels –.
https://www.medscape.com/viewarticle/958747
Dec 15th, 2021 - This transcript has been edited for clarity. Laurence Sperling, MD: Welcome to Medscape's InDiscussion series on dyslipidemia. This is episode four, "The Top 10 Take-Home Messages From the 2018 ACC/AHA Cholesterol Guidelines." Today we are fortuna...